Literature DB >> 9702744

Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder.

G Kirov1, K C Murphy, M J Arranz, I Jones, F McCandles, H Kunugi, R M Murray, P McGuffin, D A Collier, M J Owen, N Craddock.   

Abstract

Catechol-O-methyltransferase (COMT) plays a major role in the breakdown of catecholamines. An amino acid polymorphism (val-108-met) determines high and low activity of the enzyme. A recent study in a small sample of patients with velo-cardio-facial syndrome who had bipolar affective disorder suggested that the Met (low activity) COMT allele might be associated with rapid-cycling in this population. We therefore tested the hypothesis that the Met allele might be associated with rapid cycling bipolar disorder in the wider population. We studied a sample of British Caucasian DSM-IV bipolar patients, of whom 55 met criteria for rapid cycling at some time during the illness and 110 met stringent criteria for a definite non-rapid cycling course. The COMT genotype was determined using a PCR assay. The low activity allele was more frequent in the group of rapid cyclers: 0.55 vs 0.42 (one-tailed chi 2 = 5.12, d.f. = 1, P = 0.012), and bearers of low activity alleles showed a dose-dependent increased risk of lifetime occurrence of rapid cycling: chi 2 test of linear association = 4.84, d.f. = 1, P = 0.014. Our data support the hypothesis that variation in the COMT gene modifies the course of bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9702744     DOI: 10.1038/sj.mp.4000385

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  33 in total

1.  The underlying neurobiology of bipolar disorder.

Authors:  Husseini K Manji; Jorge A Quiroz; Jennifer L Payne; Jaskaran Singh; Barbara P Lopes; Jenilee S Viegas; Carlos A Zarate
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

2.  The enzymatic activities of brain catechol-O-methyltransferase (COMT) and methionine sulphoxide reductase are correlated in a COMT Val/Met allele-dependent fashion.

Authors:  Jackob Moskovitz; Consuelo Walss-Bass; Dianne A Cruz; Peter M Thompson; Jenaqua Hairston; Marco Bortolato
Journal:  Neuropathol Appl Neurobiol       Date:  2015-05-02       Impact factor: 8.090

3.  The Val/Met functional polymorphism in COMT confers susceptibility to bipolar disorder: evidence from an association study and a meta-analysis.

Authors:  Zhao Zhang; Klaus Lindpaintner; Ronglin Che; Zangdong He; Peng Wang; Ping Yang; Guoyin Feng; Lin He; Yongyong Shi
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

Review 4.  [Correlations between risk gene variants for schizophrenia and brain structure anomalies].

Authors:  T Nickl-Jockschat; M Rietschel; T Kircher
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

5.  Identification of a novel haplotype of the human catechol-O-methyltransferase gene.

Authors:  Hyoung-Woo Bai; Bao Ting Zhu
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

Review 6.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Authors:  N Craddock; M C O'Donovan; M J Owen
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

7.  Rapid cycling bipolar disorders in primary and tertiary care treated patients.

Authors:  Tomas Hajek; Margaret Hahn; Claire Slaney; Julie Garnham; Joshua Green; Martina Růzicková; Peter Zvolský; Martin Alda
Journal:  Bipolar Disord       Date:  2008-06       Impact factor: 6.744

8.  Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.

Authors:  Haraldur Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Andres Ingason; Hannes Petursson
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

9.  Personality in relation to genetic liability for schizophrenia and bipolar disorder: differential associations with the COMT Val 108/158 Met polymorphism.

Authors:  Amy L Silberschmidt; Scott R Sponheim
Journal:  Schizophr Res       Date:  2008-01-16       Impact factor: 4.939

10.  No association of COMT Val158Met polymorphism with suicidal behavior or CSF monoamine metabolites in mood disorders.

Authors:  Gil Zalsman; Yung-yu Huang; Maria A Oquendo; David A Brent; Lucas Giner; Fatemeh Haghighi; Ainsley K Burke; Steven P Ellis; Dianne Currier; J John Mann
Journal:  Arch Suicide Res       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.